Can sleep affect the life span of people with diabetes, heart disease, hypertension, or stroke? New research published in the Journal of The American Heart Association found that short sleep duration was linked to all-cause mortality for cardiometabolic risks (CMR) and cancer-related mortality for people with cerebrovascular diseases (
Carried out by the Penn State College of Medicine, the research was based on the Penn State Adult Cohort which explored the relationship between insufficient or disturbed sleep with mortality for people with CMR and CBVDs. The team studied sleeping patterns of 1654 adults (aged 20–74 years). People with stage 2 hypertension and type 2 diabetes were identified in the CMR group, while for CBVD the team picked participants who were diagnosed or were undergoing treatment for heart disease or stroke.
Objective short sleep duration was defined as less than 6 hours. The study found that objective short sleep duration for CMR was associated with 1.83 times higher risk for all-cause mortality and 2.92 times higher risk of cancer mortality of CBVD.
